Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
1 clinical trials · Condition
◉ Watch Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers (NCT01209195) | Merrimack Pharmaceuticals | 2010-10-01 |
Track Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.